Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according ...
Cancer
May 17, 2012 |
5 / 5 (4) |
0
|
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...
Cancer
May 16, 2012 |
not rated yet |
0
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
For patients with metastatic soft-tissue sarcoma whose disease has progressed following standard chemotherapy, treatment with pazopanib (a drug that targets the growth of new cancer-related blood vessels) nearly tripled progression-free ...
Cancer
May 15, 2012 |
not rated yet |
0
Protein may represent a switch to turn off B cell lymphoma
Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. Cancerous cells have been described as being "addicted" to certain ...
Cancer
May 07, 2012 |
5 / 5 (1) |
0
Study finds an on-off switch for angiogenesis
Scientists from the MIRA and MESA+ research institutes at the University of Twente (The Netherlands) have discovered an ‘on/off switch’ for angiogenesis in human tissue. Their research has shown ...
Medical research
Apr 27, 2012 |
not rated yet |
0
Study points to potential treatment for stroke
Stanford University School of Medicine neuroscientists have demonstrated, in a study to be published online April 24 in Stroke, that a compound mimicking a key activity of a hefty, brain-based protein is capable of increa ...
Cardiology
Apr 24, 2012 |
not rated yet |
0
|
New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd ...
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
Balancing trastuzumab's survival benefits and heart risks for women with breast cancer
Adding trastuzumab (trade name Herceptin) to the treatment offered to women who have HER2-positive breast cancer, significantly increases the chance of life being prolonged, and reduces the chance of tumours reappearing once ...
Cancer
Apr 17, 2012 |
not rated yet |
0
Latest research confirms genetic susceptibility to lung cancer
Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations. Furthermore, Asian patients with lung cancer are more likely to be non-smokers ...
Cancer
Apr 15, 2012 |
3 / 5 (1) |
0
Tivozanib exhibits antitumor activity in renal cancer
(HealthDay) -- The potent, selective vascular endothelial growth factor receptor-1, -2, and -3 inhibitor, tivozanib, demonstrates antitumor activity and is well tolerated in patients with advanced/metastatic ...
Cancer
Apr 10, 2012 |
not rated yet |
0
Researchers derive purified lung and thyroid progenitors from embryonic stem cells
Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have derived a population of pure lung and thyroid progenitor cells in vitro that successfully mimic the developmental milestones ...
Medical research
Apr 05, 2012 |
5 / 5 (1) |
0
|
Study finds method to improve transplant cell delivery
(Medical Xpress) -- A new technique for improving delivery of stem cells may lead to better and faster tissue repair, a breakthrough with promise for sports medicine and military populations.
Medical research
Apr 03, 2012 |
5 / 5 (1) |
0
|
Understanding individual genetic variation can help predict chemotherapy side effects
The largest study ever on the effect of genetic variability on the toxicity of chemotherapy in breast cancer shows that it is possible to predict which patients are most likely to suffer serious side effects, a researcher ...
Cancer
Mar 23, 2012 |
not rated yet |
0
New compound discovered that rapidly kills liver cancer
Scientists have identified a new compound that rapidly kills hepatocellular carcinoma (HCC) cells, the most common form of liver cancer and fifth most common cancer worldwide, while sparing healthy tissue. The compound, Factor ...
Cancer
Mar 14, 2012 |
5 / 5 (20) |
0
|
Researchers crack degeneration process that leads to Alzheimer's
A research group led by Dr. A. Claudio Cuello of McGill University's Faculty of Medicine, Dept. of Pharmacology and Therapeutics, has uncovered a critical process in understanding the degeneration of brain cells sensitive ...
Alzheimer's disease & dementia
Mar 08, 2012 |
5 / 5 (1) |
0
|
